Tryptophan and quality of life in colorectal cancer

Advances in Experimental Medicine and Biology

Volumn 527, Issue , 2003, Pages 353-358

  Huang, Andy ^a   Fuchs, Dietmar ^b   Widner, Bernhard ^b   Glover, Claire ^a   Henderson, Don C ^a   Allen Mersh, Timothy G ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; KYNURENINE; NEOPTERIN; TRYPTOPHAN;

BLOOD LEVEL; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; STATISTICAL SIGNIFICANCE;

EID: 1042291127     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0135-0_39     Document Type: Conference Paper

References (27)

1. S. Earlam, C. Glover, C. Fordy, D. Burke, TG. Allen-Mersh, Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases, J. Clin. Oncol. 14(1), 171-175 (1996).
2. T.G. Allen-Mersh, C. Glover, C. Fordy, D.C. Henderson, M. Davies, Relation between depression and circulating immune products in patients with advanced colorectal cancer, J. R. Soc. Med. 91(8), 408-413 (1998).
3. R. Dantzer, R.M. Bluthe, S. Laye, J.L. Bret-Dibat, P. Parnet, K.W. Kelley, Cytokines and sickness behavior, Ann. N. Y. Acad. Sci. 840, 586-590 (1998).
4. A. Bauhoter, K. Witte, I. Celik, S. Pummer, B. Lemmer, W. Lorenz, Sickness behaviour, an animal equivalent to human quality of life, is improved in septic rats by G-CSF and antibiotic prophylaxis, Langenbecks Arch. Surg. 386(2), 132-140 (2001).
5. C. Murr, B. Widner, B. Sperner-Unterweger, M. Ledochowski, C. Schubert, D. Fuchs, Immune reaction links disease progression in cancer patients with depression, Med. Hypotheses 55(2), 137-140 (2000).
6. E.R. Werner, G. Werner-Felmayer, D. Fuchs, A. Hausen, G. Reibnegger, H. Wachter, Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma, Biochem. J. 262(3), 861-866 (1989).
7. T. Gasse, B. Widner, G. Baier-Bitterlich, B. Sperner-Unterweger, F. Leblhuber, H. Wachter, et al., Abnormal tryptophan metabolism, neurologic/psychiatric distubances and its relationship to immune activation, in: Neurochemical markers in degenerative disorders and drug addiction. Progress in HPLC-HPCE, edited by G. Quereshi, H. Parvez, P. Caudy, S. Parvez (Utrecht, VSP Press, 1998), pp. 351-382.
8. H. Denz, B. Orth, G. Weiss, R. Herrmann, P. Huber, H. Wachter, et al., Weight loss in patients with hematological neoplasias is associated with immune system stimulation, Clin. Investig. 71(1), 37-41 (1993).
9. M.J. Owens, C.B. Nemeroff, Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter, Clin. Chem. 40(2), 288-95 (1994).
10. K.A. Smith, J.S. Morris, K.J. Friston, P.J. Cowen, R.J. Dolan, Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion, Br. J. Psychiatry 174, 525-529 (1999).
11. C.L. DeVane, Differential pharmacology of newer antidepressants, J. Clin. Psychiatry 59(Suppl 20), 85-93 (1998).
12. K.A. Smith, C.G. Fairburn, P.J. Cowen, Relapse of depression after rapid depletion of tryptophan, Lancet 349(9056), 915-919 (1997).
13. H. Iwagaki, A. Hizuta, M. Uomoto, Y. Takeuchi, S. Saito, N. Tanaka, Cancer cachexia and depressive states: a neuro-endocrine-immunological disease? Acta Med. Okayama 51(4), 233-236 (1997).
14. D. Fuchs, A.A. Moller, G. Reibnegger, E. Stockle, E.R. Werner, H. Wachter, Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms, J. Acquir. Immune Defic. Syndr. 3(9), 873-876 (1990).
15. B. Widner, E.R. Werner, H. Schennach, H. Wachter, D. Fuchs, Simultaneous measurement of serum tryptophan and kynurenine by HPLC, Clin. Chem. 43(12), 2424-2426 (1997).
16. J.C. de Haes, F.C. van Knippenberg, JP. Neijt, Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist, Br. J. Cancer. 62(6), 1034-1038 (1990).
17. A.S. Zigmond, R.P. Snaith, The hospital anxiety and depression scale, Acta Psychiatr. Scand. 67(6), 361-370 (1983).
18. M. Bergner, R.A. Bobbitt, W.B. Carter, B.S. Gilson, The Sickness Impact Profile: development and final revision of a health status measure, Med. Care 19(8), 787-805 (1981).
19. A. Huang, D. Fuchs, B. Widner, C. Glover, D.C. Henderson, T.G. Allen-Mersh, Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer, Br. J. Cancer 86(11), 1691-1696 (2002).
20. C. Murr, L.C. Fuith, B. Widner, B. Wirleitner, G. Baier-Bitterlich, D. Fuchs, Increased neopterin concentrations in patients with cancer: indicator of oxidative stress? Anticancer. Res. 19(3A), 1721-1728 (1999).
21. A. Diez-Ruiz, G.P. Tilz, R. Zangerle, G. Baier-Bitterlich, H. Wachter, D. Fuchs, Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis, Eur. J. Haematol. 54(1), 1-8 (1995).
22. G.B. Mills, R. Schmandt, S. Gibson, B. Leung, M. Hill, C. May, et al., Transmembrane signaling by the interleukin-2 receptor: progress and conundrums, Semin. Immunol. 5(5), 345-364 (1993).
23. G. Reibnegger, D. Fuchs, L.C. Fuith, A. Hausen, E.R. Werner, G. Werner-Felmayer, et al., Neopterin as a marker for activated cell-mediated immunity: Application in malignant disease, Cancer Detect. Prevent. 15, 483-490 (1991).
24. C. Murr, A. Bergant, M. Widschwendter, K. Heim, H. Schröcksnadel, D. Fuchs, Neopterin is an independent prognostic parameter in females with breast cancer, Clin. Chem. 45, 1998-2004 (1999).
25. R.M. Giusti, E.M. Maloney, B. Hanchard, O.S.C. Morgan, S.M. Steinberg, H. Wachter, et al., Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic pararesis and adult T-cell leukemia/ lymphoma, Cancer Epidemiol. Biomarkers Prevent. 5, 699-709 (1996).
26. K. Saito, S.P. Markey, M.P. Heyes, Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse, Neuroscience 51(1), 25-39 (1992).
27. M.F. Murray, M. Langan, R.R. MacGregor, Increased plasma tryptophan in HIV-infected patients treated with pharmacologic doses of nicotinamide, Nutrition 17(7-8), 654-656 (2001).